Pfizer Income from Discontinued Operations 2010-2024 | PFE

Pfizer income from discontinued operations for the twelve months ending December 31, 2024 was $-2M, a 108.33% decline year-over-year.

  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 0% decline from 2024.
  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 173.33% decline from 2023.
  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 0% decline from 2023.

Pfizer Income from Discontinued Operations 2010-2024 | PFE

  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 0% decline from 2024.
  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 173.33% decline from 2023.
  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 0% decline from 2023.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B